Literature DB >> 10357096

Pathogenesis of testicular germ cell tumours.

L H Looijenga1, J W Oosterhuis.   

Abstract

Human germ cell tumours comprise a heterogeneous group of neoplasms. In the testis, three entities are distinguished, the teratomas-yolk sac tumours of the infantile testis, the seminomas and nonseminomas of adolescents and adults, and the spermatocytic seminomas. Studies on epidemiology, histology, clinical behaviour, and chromosomal constitution of these tumours support the concept of distinct entities derived from germ cells but each with a different pathogenesis. Either the teratomas of the infantile testis show no chromosomal aberrations, or display a pattern of over- and under-representation of (parts of) chromosomes as detected in the yolk sac tumours of the infantile testis. In contrast, the seminomas and nonseminomas reveal a consistent pattern of losses and gains, that is, chromosomes 11, 13 and 18, and 7, 8 and X, respectively, that is different from that found in the infantile testis teratomas and yolk sac tumours. The most consistent structural chromosomal abnormality is an isochromosome 12p. Tumours lacking i(12p) have other structural abnormalities of 12p, among them amplification of 12p11.2-p12.1. The pathogenetically relevant genes on 12p11.2-p12.1 are probably on a fragment of about 1.7 mb. Gain of 12p sequences may be related to invasive growth. Gain of chromosome 9 is the only consistent chromosomal anomaly of spermatocytic seminomas. Infantile teratomas and spermatocytic seminomas are benign tumours. Infantile yolk sac tumour is a malignant germ cell tumour. Seminomas and nonseminomas are malignant, and the most common cancer in young Caucasian males. The cure rate of seminomas and non-seminomas with radio- and chemotherapy is over 90%, which is higher than that of any other solid cancer in adults. In addition, the precursor lesions of these tumours can be treated readily, justifying efforts to develop means for early diagnosis. Finally, the pathogenetic relationship between seminomas and nonseminomas, and the available animal models for the three groups of testicular germ cell tumours are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10357096     DOI: 10.1530/ror.0.0040090

Source DB:  PubMed          Journal:  Rev Reprod        ISSN: 1359-6004


  36 in total

1.  Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.

Authors:  Carsten Kempkensteffen; Frank Christoph; Steffen Weikert; Hans Krause; Jens Köllermann; Martin Schostak; Kurt Miller; Mark Schrader
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

2.  Inguinal lymphnode metastatic testicular seminoma: a case report and review of literature.

Authors:  Shishir Shah; Hemang Bakshi
Journal:  Indian J Surg Oncol       Date:  2011-12-23

3.  Sin3a is required by sertoli cells to establish a niche for undifferentiated spermatogonia, germ cell tumors, and spermatid elongation.

Authors:  Christopher J Payne; Shannon J Gallagher; Oded Foreman; Jan Hermen Dannenberg; Ronald A Depinho; Robert E Braun
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

4.  Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells.

Authors:  Ralph Brehm; Christina Rüttinger; Petra Fischer; Isabella Gashaw; Elke Winterhager; Sabine Kliesch; Rainer M Bohle; Klaus Steger; Martin Bergmann
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

Review 5.  Human spermatogonial stem cells: a possible origin for spermatocytic seminoma.

Authors:  R Waheeb; M-C Hofmann
Journal:  Int J Androl       Date:  2011-08

Review 6.  [Genetics of testicular germ cell tumors].

Authors:  I Verdorfer
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

7.  Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas.

Authors:  Salvatore Ulisse; Enke Baldini; Marcella Mottolese; Steno Sentinelli; Patrizia Gargiulo; Brancato Valentina; Salvatore Sorrenti; Anna Di Benedetto; Enrico De Antoni; Massimino D'Armiento
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

8.  Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Authors:  B Nitzsche; C Gloesenkamp; M Schrader; M Ocker; R Preissner; M Lein; A Zakrzewicz; B Hoffmann; M Höpfner
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

9.  High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.

Authors:  Hadi Shojaei; Hong Hong; Raymond W Redline
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

10.  Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.

Authors:  Kevin M Kernek; Thomas M Ulbright; Shaobo Zhang; Steven D Billings; Oscar W Cummings; John D Henley; Helen Michael; Matteo Brunelli; Guido Martignoni; Richard S Foster; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.